Volume 27, Issue 2 (Iran South Med J 2024)                   Iran South Med J 2024, 27(2): 171-178 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mahi-Birjand M, Shabani A R, Khosrojerdi A, Alemzadeh E, Elhamirad S, Ziaee M. Investigating the Efficacy of Vaccination Against Hepatitis B in Families of Infected Patients: in a Hyperendemic Area of Iran. Iran South Med J 2024; 27 (2) :171-178
URL: http://ismj.bpums.ac.ir/article-1-2017-en.html
1- Department of Clinical Pharmacy, School of Pharmacy, Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
2- Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
3- Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran , dr.m.ziaee@gmail.com
Abstract:   (698 Views)
Background: Hepatitis B virus (HBV) is recognized as a leading cause of liver disease globally, resulting in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. With an estimated 296 million people infected worldwide and an annual mortality rate of around 820,000, hepatitis B presents a significant public health challenge. The virus is transmitted through blood and bodily fluids, with particular significance given to vertical transmission (from parents to children) and horizontal transmission (between spouses), especially in hyperendemic regions.
Materials and Methods: This retrospective descriptive study examined the prevalence of hepatitis B among families in Esfandiar village, a hyperendemic area in Iran. The research involved 133 individuals who tested positive for HBsAg and 199 of their family members. Key demographic characteristics, infection factors (HbsAg status), and antibody titers were analyzed.
Results: The results indicated that 15.4% of the spouses and 5% of the children of the patients were HBsAg-positive, while 21% of their children had a history of infection with HBV. Furthermore, vaccination history revealed that only 0.9% of vaccinated individuals were HBsAg-positive, compared to a striking 40% positivity rate among the unvaccinated.
Conclusion: These findings highlight the critical role of familial transmission of hepatitis B, particularly between couples and from parents to children. They also underscore the importance of vaccination and health education in curbing the spread of this disease.
Full-Text [PDF 361 kb]   (282 Downloads)    
Type of Study: Original | Subject: infectious
Received: 2024/08/9 | Accepted: 2024/11/17 | Published: 2024/12/7

References
1. Mao W, Wu J. Haematologic indices in hepatitis B virus-related liver disease. Clinica Chimica Acta 2020; 500: 135-42. [DOI]
2. Javanmard D, Alavian SM, Abedi F & et al. High prevalence of hepatitis B virus infection in the Village of Esfandiar in South Khorasan Province, Iran. Hepatitis Monthly 2018; 18(8): e65473. [DOI]
3. Soufian M, Mahdaviani F S, Izadi N & et al. Comparison the prevalence of isolated Hepatitis B core antibody among injection drug users with blood donors in central province in IRAN. Iran South Med J 2011; 14(3): 173-178. (Persian) [Article]
4. Revill PA, Chisari FV, Block JM & et al. A global scientific strategy to cure hepatitis B. lancet Gastroenterol hepatol 2019; 4(7): 545-58. [DOI]
5. Osmani F, Azarkar G. Fitting logistic regression models to assess vitamin D deficiency with clinical parameters in chronic hepatitis B patients. Infect Dis Mod 2021; 6: 612-7. [DOI]
6. Esmaieli H, Hajiani G, Mankhian A & et al. Seroepidemiological survey of hepatitis B, C, HIV and syphilis among blood donors in Bushehr-Iran. Iran South Med J 2009; 11(2): 183-190. (Persian) [Article]
7. Yousefi M, Sharifzadeh GR, Ebrahimzadeh A & et al. Prevalence and associated risk factors of htlv1 and co-infections of blood-borne viruses in Birjand, Iran’s eastern border. Arch Iran Med 2020; 23(10): 672-7. [DOI]
8. Veronese P, Dodi I, Esposito S & et al. Prevention of vertical transmission of hepatitis B virus infection. World J Gastroenterol 2021; 27(26): 4182. [DOI]
9. Razavi H. Global epidemiology of viral hepatitis. Gastroenterol Clin North Am 2020; 49(2): 179-89. [DOI]
10. Schmit N, Nayagam S, Thursz MR & et al. The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups. Int J epidemiol 2021; 50(2): 560-9. [DOI]
11. Kafeero HM, Ndagire D, Ocama P, Kudamba A, Walusansa A, Sendagire H. Prevalence and predictors of hepatitis B virus (HBV) infection in east Africa: evidence from a systematic review and meta-analysis of epidemiological studies published from 2005 to 2020. Arch Public Health 2021; 79(1): 167. [DOI]
12. Razavi-Shearer D, Gamkrelidze I, Pan C & et al. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol 2023; 8(10): 879-907. [DOI]
13. Javanmard D, Namaei MH, Farahmand M & et al. Molecular and serological characterization of occult hepatitis B virus infection among patients with hemophilia. J Med Virol 2019; 91(8): 1519- 27. [DOI]
14. Khan A, Ahmad I, Ahmad Z. Intra-Familial Spread of HBV among HbsAg Positive Parents and their Children in a Defined Rural Community of District Peshawar, Pakistan. Pak J Public Health 2023; 13(1): 11-4. [DOI]
15. WHO. Guidelines for the prevention care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization. (Accessed Mar 1, 2015. [Article]
16. Rezaei N, Asadi-Lari M, Sheidaei A & et al. Epidemiology of hepatitis B in Iran from 2000 to 2016: a systematic review and meta-regression analysis. Arch Iran Med 2020; 23(3): 189-96. [Article]
17. Kinfe H, Sendo EG, Gebremedhin KB. Prevalence of hepatitis B virus infection and factors associated with hepatitis B virus infection among pregnant women presented to antenatal care clinics at Adigrat General Hospital in Northern Ethiopia. Int J Women's Health 2021: 119-27. [DOI]
18. Alavian SM, Hosseini SM, Fattahi E & et al. Determination of hepatitis b frequency among family members of hbsag+ in military and non-military persons. 2004; 6 (16): 99-104. [Article]
19. Azarkar G, Ziaee M, Bijari B & et al. Interspousal Transmission of Hepatitis B virus: A Cross-Sectional Descriptive-Analytical Study. Mod Care J 2017; 14(2): e65738. [DOI]
20. Pourshams A, Nasiri J, Mohammadkhani A & et al. Hepatitis B in Gonbad-Kavoos: prevalence, risk factors and intrafamilial spreading. Govaresh 2004; 9(4): 222-5. [Article]
21. Labarrere CA, Woods J, Hardin J & et al. Early prediction of cardiac allograft vasculopathy and heart transplant failure. Am J Transplant 2011; 11(3): 528-35. [DOI]
22. Erol S, Ozkurt Z, Ertek M & et al. Intrafamilial transmission of hepatitis B virus in the eastern Anatolian region of Turkey. Eur J Gastroenterol hepatol 2003; 15(4): 345-9. [DOI]
23. Salkic NN, Zildzic M, Muminhodzic K, PavlovicCalic N, Zerem E, Ahmetagic S, et al. Intrafamilial transmission of hepatitis B in Tuzla region of Bosnia and Herzegovina. Eur J gastroenterol hepatol 2007; 19(2): 113-8. [DOI]
24. Ucmak H, Kokoglu OF, Celik M & et al. Intra-familial spread of hepatitis B virus infection in eastern Turkey. Epidemiol Infec 2007; 135(8): 1338-43. [DOI]
25. Sofian M, Banifazl M, Ziai M & et al. Intra-familial transmission of hepatitis B virus infection in Arak, central Iran. Iran J pathol 2016; 11(4): 328-33. [Article]
26. Alizadeh AHM, Ranjbar M, Ansari S & et al. Intrafamilial prevalence of hepatitis B virologic markers in HBsAg positive family members in Nahavand, Iran. World J Gastroenterol: WJG 2005; 11(31): 4857-60. [DOI]
27. Khetsuriani N, Gamkrelidze A, Shadaker S & et al. Toward reaching hepatitis B goals: hepatitis B epidemiology and the impact of two decades of vaccination, Georgia, 2021. Euro surveill 2023; 28(30): 2200837. [DOI]
28. Cheng T-W, Yang J-F, Chen Y-Y & et al. Epidemiology of chronic hepatitis B infection in the cohort of college students with vaccination in Taiwan. Vaccines 2023; 11(2): 348. [DOI]

Send email to the article author


Rights and Permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Iranian South Medical Journal

Designed & Developed by: Yektaweb